DSIP Half-Life & Stability
Part of the full DSIP guide - a endogenous amphiphilic neuropeptide reference compound, identity-verified with a COA on every vial.
In brief
Peptide-specific pharmacokinetic constants are not provided in the DSIP entry, so this spoke separates the few peptide-specific facts that the data supports from general peptide-class stability and storage principles, which are clearly labeled as general where DSIP-specific values are absent.
The detail
A closer look
01
What the data does and does not specify
The provided entry supplies DSIP's identity (nonapeptide, sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, 848.81 g/mol, formula C35H48N10O15) and its origin (first isolated 1977 from rabbit cerebral venous blood), but it does not state a half-life, clearance rate, or degradation half-time. No PK value should be inferred or quoted for DSIP from this reference set. The discussion below is therefore general peptide-class stability framing applied to a short nonapeptide, offered only to inform laboratory handling, not to assert DSIP-specific kinetics.
02
General degradation considerations for short peptides
As a general principle for small linear peptides, the dominant in-vitro stability concerns are hydrolysis of peptide bonds and, in biological matrices, cleavage by peptidases. Reconstituted aqueous solutions are generally less stable than the lyophilized solid because water participates in hydrolytic breakdown. DSIP's amphiphilic character and short nine-residue length are structural facts from the entry; how they translate into a numerical degradation rate is not specified by the provided data and would require empirical measurement not contained in this reference.
03
Storage as the practical control
Because the supplied data gives no DSIP-specific shelf-life figure, storage discipline is the practical lever a researcher controls. General good practice for lyophilized reference peptides is to keep the solid cold and dry until reconstitution, then to refrigerate the working solution, minimize warming cycles, and aliquot for longer-term frozen storage to limit repeated freeze-thaw. The N-terminal tryptophan that gives DSIP its UV-absorbance signature also offers a built-in, non-destructive way to monitor the peptide spectrophotometrically over a storage period in the lab.
The fine print: products are sold for laboratory research use only and are not for human or animal consumption. Bodily introduction into humans or animals is strictly prohibited by law. DSIP is not a drug and is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA.